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Abstract
Incorporation of engineered nanomaterials (ENMs) into toners used in laser printers has led to 
countless quality and performance improvements. However, the release of ENMs during printing 
(consumer use) has raised concerns about their potential adverse health effects. The aim of this 
study was to use “real world” printer-emitted particles (PEPs), rather than raw toner powder, and 
assess the pulmonary responses following exposure by intratracheal instillation. Nine-week old 
male Balb/c mice were exposed to various doses of PEPs (0.5, 2.5 and 5 mg/kg body weight) by 
intratracheal instillation. These exposure doses are comparable to real world human inhalation 
exposures ranging from 13.7 to 141.9 h of printing. Toxicological parameters reflecting distinct 
mechanisms of action were evaluated, including lung membrane integrity, inflammation and 
regulation of DNA methylation patterns.
Results from this in vivo toxicological analysis showed that while intratracheal instillation of PEPs 
caused no changes in the lung membrane integrity, there was a pulmonary immune response, 
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indicated by an elevation in neutrophil and macrophage percentage over the vehicle control and 
low dose PEPs groups. Additionally, exposure to PEPs upregulated expression of the Ccl5 
(Rantes), Nos1 and Ucp2 genes in the murine lung tissue and modified components of the DNA 
methylation machinery (Dnmt3a) and expression of transposable element (TE) LINE-1 compared 
to the control group. These genes are involved in both the repair process from oxidative damage 
and the initiation of immune responses to foreign pathogens. The results are in agreement with 
findings from previous in vitro cellular studies and suggest that PEPs may cause immune 
responses in addition to modifications in gene expression in the murine lung at doses that can be 
comparable to real world exposure scenarios, thereby raising concerns of deleterious health 
effects.
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1. Introduction
The use of laser printers leads to exposure to various pollutants, including ozone, volatile 
organic compounds and particulate matter (PM), among other pollutants (He et al., 2007; 
Morawska et al., 2009; Wang et al., 2012). In particular, the release of a significant number 
of particles, the majority of which are nanoparticles, during the use of this growing 
technology has become a reason for concern. More recently, in order to assess the complex 
chemistry of printer emitted particles (PEPs) and their potential health hazards, a Printer 
Exposure Generation System (PEGS) was recently developed to generate and sample 
airborne PEPs for subsequent physicochemical, morphological and toxicological analyses 
(Pirela et al., 2014a). The PM emission profiles from commonly used printers were 
evaluated and further characterization was performed on both raw toner powder and PEPs. 
The detailed analysis showed that laser printers emit up to 1.3 million particles/cm3 with 
modal diameters of b200 nm (Pirela et al., 2014a). More importantly, Pirela et al. (2014b) 
found nanoscale materials used in the toner formulation that become airborne during the use 
of a printer, thus, classifying toners as nano-enabled products (NEPs). Additionally, the 
authors found that toner powders and PEPs share a complex chemistry and contain 
elemental and organic carbon, as well as inorganic compounds such as nanoscale metals and 
metal oxides.
While the physicochemical and morphological properties of PEPs have been studied in 
detail, their toxicological profiles remain largely unknown. In a series of recently published 
papers, several physiologically relevant cell lines (i.e., human small airway epithelial cells, 
microvascular endothelial cells, macrophages and lymphoblasts) were treated with various 
doses of PEPs using both mono- and co-culture exposure systems (Sisler et al., 2014; Pirela 
et al., 2015). In both studies, it was shown that PEPs triggered an unfavorable series of 
biological responses in macrophages, small airway epithelial cells and microvascular 
endothelial cells at doses comparable to approximately 8 h or more of consumer inhalation 
of PEPs. Specifically, cell treatment with PEPs led to significant changes in cell viability, 
hereditary genetic material changes, reactive oxygen species (ROS) generation and release 
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of inflammatory mediators, among other adverse effects. Moreover, recent findings suggest 
that PEPs can also influence the cellular epigenome. Particularly, a 24-hour exposure to 
PEPs caused altered expression of DNA methylation machinery in small airway epithelial 
cells, in turn leading to changes in global DNA methylation and reactivation of transposable 
element (TE) LINE-1 and Alu (Pirela et al., 2015; Lu et al., 2015a).
Notably, the toxicity of PEPs remains poorly characterized in vivo with only a few 
published studies. Major discrepancy on those in vivo studies is the use of toner powders 
rather than the PM and gaseous pollutants emitted from laser printers. For example, Bai, 
Zhang (Bai et al., 2010) reported that mice exposed to printer toner particles showed 
significant pulmonary inflammation, damage to the epithelial-capillary barrier and enhanced 
cell permeability. Comparable inflammatory and fibrotic responses were also observed in 
rats exposed to toner powders (Morimoto et al., 2013). A historic rodent chronic inhalation 
exposure concluded that toner led to a substantial increase in lung weight, a chronic 
inflammatory response, pulmonary fibrosis and increased incidence of primary lung tumors 
in exposed rats (Muhle et al., 1991). However, as extensive as these studies were in 
identifying the biological response in the rodent lung following exposure to toner, they are 
limited by addressing only the toxicity of toner powder, which may be relevant to 
occupational settings and workers directly handling toner powders but is not applicable to 
consumers using laser printers.
In this study, we sought to further expand on the latest cellular toxicology studies performed 
by our group on PEPs (Sisler et al., 2014; Pirela et al., 2015; Lu et al., 2015b). Particularly, 
we present findings on the murine responses to intratracheal instillation exposures to various 
doses of PEPs. The endpoints evaluated included bronchoalveolar lavage (BAL) levels of 
lactate dehydrogenase, myeloperoxidase, cytokines and white blood cell differentials, as 
well as lung tissue expression of a number of genes involved in immune responses, cell 
survival and signaling, among other important biological processes.
2. Material and methods
2.1. Experimental design
Fig. 1 shows the experimental setup of the previously developed Printer Exposure 
Generation System (PEGS, (Pirela et al., 2014a)) used in this study. It consists of: a) a 
glovebox type environmental chamber to house the printer used in this study (Printer B1 in 
our previous publications: (Pirela et al., 2014a; Pirela et al., 2014b)) for uninterrupted 
operation; b) real time and time-integrated PM sampling and monitoring instrumentation to 
quantify particle size distribution and collect size-fractionated PEPs for analysis; and c) an 
animal inhalation exposure system for toxicological evaluation.
Groups of mice were exposed to various exposure doses of the smallest size fraction of PEPs 
(particles with an aerodynamic diameter smaller than 0.1 μm, PM0.1) by intratracheal 
instillation. Following the exposure, animals were sacrificed and BAL was performed. The 
BAL fluid (BALF), blood and lung tissue were subsequently used to measure biochemical 
markers of inflammation, albumin and hemoglobin levels, white blood cell differentials and 
expression of a number of genes in addition to epigenetic analyses. In more detail:
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2.2. Exposure characterization, sample preparation of size-fractionated airborne PM for 
intratracheal instillation exposures
2.2.1. Real time instrumentation for PM—A water-based condensation particle 
counter (WCPC Model 3785, TSI Inc., Shoreview, MN) was used to monitor the number 
concentration of particles sized from 5 to 1000 nm. A scanning mobility particle sizer 
(SMPS Model 3080, TSI Inc., Shoreview, MN) was also used in order to measure the 
particle size distribution (ranging from 2.5 to 210 nm) in the chamber. All the instruments 
were calibrated and background tests were performed at the beginning of each sampling 
experiment.
2.2.2. Size-selective integrated PM sampling and colloidal suspension 
preparation—The Harvard compact cascade impactor CCI, (Demokritou et al., 2004) was 
used to size fractionate and collect PM samples. The CCI operates with four stages and 
allows for collection of moderately large amounts of particles (mg level) for the following 
size fractions: PM2.5–10, PM0.1–2.5 and PM0.1. The main advantage of CCI is the fact that 
size-fractionated PM is collected on pre-cleaned adhesive-free polyurethane foam (PUF) 
impaction substrates and Teflon filters from which the particles can be efficiently extracted 
using a water-based protocol. In summary, particles in the sampling substrates are extracted 
in deionized water (DI H2O) using a sonication protocol to allow for maximum extraction 
efficiency, no chemical alteration of the extracted particles and final particle suspension that 
is representative of the aerosol composition (Demokritou et al., 2004; Pirela et al., 2013; 
Chang et al., 2013; Pal et al., 2015; Khatri et al., 2013). In this study the PM0.1 size fraction 
was instilled. Thus, the extracted PEPs (PM0.1 size fraction) were dispersed in DI H2O and 
the particle suspension characterized using a protocol developed by the authors (Cohen et 
al., 2012). In summary, the critical delivered sonication energy (DSEcr), hydrodynamic 
diameter (dH), polydispersity index (PdI), zeta potential (ζ), and specific conductance (σ) 
were measured for all particle suspensions used in the study.
2.3. Intratracheal instillation exposures
2.3.1. Animals—Nine-week-old Balb/c male mice weighing an average of 24.25 ± 1.92 g 
were purchased from Taconic Farms Inc. (Hudson, NY). Mice were housed in groups of 4 in 
polypropylene cages and allowed to acclimate for 1 week before the studies were initiated. 
Mice were maintained on a 12-hour light/dark cycle. Food and water were provided ad 
libitum. All the animal protocols used in this study were approved by the Harvard Medical 
Area Institutional Animal Care and Use Committee (IACUC).
Once the particle suspensions were prepared for the intratracheal instillation exposure, as 
described above, each mouse was weighed and their respective exposure dose calculated at 
2.5 mL/kg bw. The dosing solution was measured in a sterile syringe with an attached blunt-
tipped 21-gauge gavage needle. The mice were anesthetized with vaporized isoflurane, 
quickly restrained on a slanted board and held upright by their upper incisor teeth resting on 
a rubber band. As the animals were under anesthesia, the tip of the needle was gently 
inserted into the trachea between the vocal cords, with the tip just above the tracheal 
bifurcation, and the dosing suspension was delivered in one bolus. The mice received an 
intratracheal instillation of PEPs (PM0.1) at 0.5, 2.5 and 5.0 mg/kg bw or vehicle control (DI 
Pirela et al. Page 4
NanoImpact. Author manuscript; available in PMC 2016 March 15.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
H2O). After instillation, the animal was allowed to recover from anesthesia in a slanted 
position while the thorax was gently massaged to facilitate distribution of the instillate 
throughout the lungs. Each exposure group contained 3 or more mice.
It is worth noting that for this particular study, intratracheal instillation was chosen for 
exposure of mice to PEPs for various reasons primarily because intratracheal instillation 
allows for the delivery of a specific and accurate amount (dose) of PEPs and also to shorten 
exposure times and associated costs. The doses selected are specifically related to exposure 
durations (14, 71 and 142 h) occurring in the real world. While we recognized the pitfalls of 
using such a “bolus” method to expose animals (e.g., uniformity of delivery of the solution, 
dose rate issue), intratracheal instillation has been used routinely in the particle toxicology 
arena and it is widely accepted (Brain et al., 1976; Osier and Oberdorster, 1997; Driscoll et 
al., 2000). The 142-hour equivalent inhalation exposure dose was added in the study as a 
high dose in order to have a complete dose–response relationship assessment.
2.4. In vivo dosimetry considerations
Firstly, the mass of PEPs delivered to each mouse following intratracheal instillation of 
PEPs at the doses of 0.5, 2.5 and 5.0 mg/kg body weight was calculated using the average 
murine body weight of the mice used in the study (24.25 g). Secondly, the corresponding 
mass of PEPs instilled per lung surface area (mouse lung surface area = 82.2 cm2) to each 
mouse was calculated to be 1475, 7375 and 14,751 μg/m2, respectively. This delivered mass 
per lung surface area was matched for the human lung. The human deposition mass flux (μg/
min·m2, mass per time and surface area) of the PEPs calculated by the Multiple Path Particle 
Deposition model (MPPD2) (Anjilvel and Asgharian, 1995) was used to determine the 
equivalent inhalation exposure time (min, hours) for each instilled mass of PEPs per surface 
area (μg/m2). Table 1 summarizes the parameters used for the MPPD2 simulation, which 
include both the human breathing parameters (tidal volume, breathing frequency, inspiratory 
fraction, pause fraction, functional residual capacity, head volume, breathing route) and the 
PEP airborne nanoparticle size distribution values (count median diameter, geometric 
standard deviation, particle mass concentration).
2.5. Bronchoalveolar lavage and analysis performed post-exposure to PEPs
Twenty-four hours after intratracheal instillations to PEPs, mice were given a fatal dose by 
intraperitoneal injection of FatalPlus (0.1–0.2 mL) and sacrificed by exsanguination, 
followed by bronchoalveolar lavage (BAL). The lungs were lavaged in situ with 12 washes 
of 0.75 mL of sterile 0.9% saline. The first two washes were pooled for biochemical assays. 
Cells were separated from the supernatant in all washes (400 ×g at 40 °C for 10 min). Total 
and differential cell counts, as well as hemoglobin measurements were made from the cell 
pellets. Total cell counts were performed manually using a hemocytometer. Cell smears 
were made with a cytocentrifuge (Shandon Southern Instruments, Inc., Sewickley, PA) and 
stained with Diff-Quick (American Scientific Products, McGaw Park, IL). Differential cell 
counts were performed by counting 200 cells per mouse. The supernatant fraction of the first 
two washes was clarified by sedimentation at 15,000 ×g for 30 min and used for 
measurement of enzyme activity, albumin and cytokine measurements. Standard 
spectrophotometric assays were used for lactate dehydrogenase (LDH), myeloperoxidase 
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(MPO), albumin, and hemoglobin to identify damage to the lungs as described in Beck, 
Brain (Beck et al., 1982).
2.6. Multiplex cytokine analysis
Cytokine levels in BAL fluid were measured by Eve Technologies Corporation (Calgary, 
Alberta, Canada) using a MILLIPLEX Mouse Cytokine/Chemokine 32-plex kit (Millipore, 
St. Charles, MO) according to the manufacturer's protocol. The 32-plex consisted of eotaxin, 
granulocyte colony-stimulating factor (G-CSF), granulocyte macrophage colony-stimulating 
factor (GM-CSF), interferon (IFN)-gamma, interleukin (IL)-1alpha, IL-1beta, IL-2, IL-3, 
IL-4, IL-5, IL- 6, IL-7, IL-9, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-15, IL-17, IFN 
gamma-induced protein (IP)-10, keratinocyte chemoattractant (KC), leukemia inhibitory 
factor (LIF), CXC motif ligand (LIX), monocyte chemoattractant protein (MCP)-1, 
macrophage (M)-CSF, monokine induced by gamma interferon (MIG), macrophage 
inflammatory protein (MIP)-1alpha, MIP-1beta, MIP-2, chemokine C-C motif ligand 5 
(CCL5/RANTES), tumor necrosis favotor (TNF)-alpha, and vascular endothelial growth 
factor (VEGF). The sensitivities of the assay to these markers ranged from 0.3 to 63.6 
pg/mL.
2.7. Gene expression analysis
The RNA from the lungs of mice instilled with PEPs (2.5 mg/kg) or vehicle control (DI 
H2O) was isolated. cDNA was amplified following the manufacturer protocol of the High 
Capacity cDNA Reverse Transcription kit (Applied Biosystems). The cDNA was used to 
analyze the following genes: epidermal growth factor receptor (Egfr), glutathione peroxidase 
1 (Gpx1), peroxisome proliferator-activated receptor gamma (Pparg), signal transducer and 
activator of transcription 3 (Stat3), vascular endothelial growth factor a (Vegfa), regulatory 
subunit of type II protein kinase a R-subunit domain containing 1 (Riiad1), aldehyde oxidase 
1 (Aox1), superoxide dismutase 1 (Sod1), transforming growth factor beta 1 (Tgfb1), nitric 
oxide synthase 1 (Nos1), Ccl5, B-cell lymphoma 2 (Bcl2), uncoupling protein 2 (Ucp2), 
serine—threonine protein kinase 1 (Akt1) and DNA (cytosine-5)-methyltransferase 3A 
(Dnmt3a) using TaqMan Universal polymerase chain reaction (PCR) Master Mix and 
TaqMan primers according to manufacturer guidelines. Relative gene expression was 
analyzed using the 2−ΔΔCT method with polymerase (RNA) II (DNA directed) polypeptide 
A (POLR2a) as the internal control.
2.8. Methylation and expression analysis of transposable element LINE-1
RNA and DNA were extracted simultaneously from flash-frozen cells and lung tissue of 
mice instilled with PEPs (2.5 mg/kg) or vehicle control (DI H2O) using the AllPrep Mini Kit 
(Qiagen, Valencia, CA) for simultaneous RNA and DNA isolation according to the 
manufacturer's protocol. Analyses of methylation and expression of LINE-1 were performed 
by methylation-sensitive qRT-PCR as reported earlier in detail by the authors (Lu et al., 
2015a). Briefly, 1 μg of genomic DNA was digested with 1 U of SmaI enzyme in 1X 
CutSmart buffer at 25 °C for 2 h. This was followed by a 16 h digestion at 37 °C in the 
presence of 1 U of the enzymes HpaII, HhaI, and AciI in 1X CutSmart buffer. The digestion 
was finalized by adding 0.5 U of BstUI enzyme in 1X CutSmart buffer for 4 h at 60 °C. All 
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enzymes were purchased from New England Biolabs (Ipswich, MA, USA). Digested DNA 
was then analyzed by qRT-PCR on a ViiA 7 Real-Time PCR System (Applied Biosystems, 
Forrest City, CA, USA). DNA samples not digested with the restriction enzyme mix served 
as positive control, while samples 1) lacking the specific primers for DNA amplification 
and/or DNA template and 2) RAW264.7-derived DNA pre-treated with 5-azacytidine, a 
potent demethylating agent, served as negative controls. The threshold cycle (Ct) was 
defined as the fractional cycle number that passes the fixed threshold. The Ct values were 
converted into the absolute amount of input DNA using the absolute standard curve method 
and further normalized towards rDNA readings.
2.9. Statistical analysis
Statistical analyses were performed using GraphPad Prism 6.0 (La Jolla, CA). Comparisons 
between all bronchoalveolar lavage fluid parameters after exposure to all doses of PEPs and 
vehicle control were evaluated using one-way analysis of variance (ANOVA) and Tukey 
correction for multiple comparison statistical significance. A p-value of 0.05 was considered 
significant. It is worth noting that the Kolmogorov–Smirnov normality test was used to 
assess the normality of the distribution of the dataset. The D'Agostino & Pearson omnibus 
and the Shapiro–Wilk normality tests were also run to assess normality of distribution. 
However, due to a small sample size, the D'Agostino & Pearson omnibus and the Shapiro–
Wilk normality tests were unable to produce results regarding the normality of the data. 
However, it is expected that the data from animal studies to follow a Gaussian distribution 
and knowing that the control exposure group for this study is normally distributed, we 
assumed the rest of the data from the PEPs exposed groups also follow the same 
distribution.
3. Results
3.1. Characterization of PEP exposure
3.1.1. PEP size distribution—The complete description of the PEP size distribution of 
Printer B1 has been previously published (Pirela et al., 2014a). In summary, Printer B1 
emitted close to 1.26 million particles/cm3 with a PM2.5 mass concentration of 
approximately 50 μg/m2. Furthermore, the PM emitted by Printer B1 had an average 
mobility diameter of 38.17 nm. It is also worth noting that detailed chemical analysis of the 
PEPs revealed a complex mixture consisting of 62 and 97% organic, 10 and 0.5% elemental 
carbon, ~ 3% metal/metal oxides (e.g., aluminum, titanium) and ~ 25% other (e.g., 
phosphorus, sulfur) (Pirela et al., 2014b).
3.1.2. Colloidal properties of PEPs used in the IT study—Table 3 summarizes the 
particle behavior in suspension as described by diameter (dH), zeta potential (ζ), 
polydispersity index (PdI) and specific conductance (σ). Briefly, PEPs (PM0.1) suspended in 
DI H2O were generally monodispersed exhibiting a PdI of 0.4 and had an average 
hydrodynamic diameter of approximately 180 nm.
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3.2. In vivo dosimetry considerations
Fig. 2 shows the mass flux in humans following exposure to PEPs, estimated to be 1.732 μg/
min·m2 by the MPPD2 model, as a function of the human respiratory system. Table 2 shows 
the doses of intratracheal instillation exposure to PEPs performed in this study and the 
equivalent inhalation time a consumer would have to be exposed to PEPs to obtain the same 
deposition mass per lung surface area, which ranged from 13.7 to 141.9 h for the 
intratracheally instilled doses of 0.5, 2.5, 5.0 mg/kg.
3.3. Biological response in a mouse model following exposure to PEPs by intratracheal 
instillation
In order to assess the potential toxicity of PEP exposure by intratracheal instillation, mice 
treated with 0.5, 2.5 and 5.0 mg/kg of PEPs or DI H2O (vehicle control) were sacrificed 24-
hours post-exposure for the following analysis:
3.3.1. Pulmonary membrane integrity and neutrophil degranulation—The BALF 
from mice exposed to 0.5, 2.5 and 5.0 mg/kg of PEPs (PM0.1) was evaluated and compared 
to that of the vehicle control group (DI H2O). No significant differences in lactate 
dehydrogenase or myeloperoxidase were observed between the PEPs and the control 
treatment groups. Further, no differences were observed in the levels of hemoglobin or 
albumin across the different treatment groups (data not shown).
3.3.2. Inflammatory cellular response—Significant differences in white blood cell 
population were detected in the percent and number of neutrophils (Fig. 3A and B) as well 
as percent macrophages and lymphocytes (Fig. 3C and D) present in the BALF of mice 
exposed to PEPs at the highest dose (5 mg/kg) compared to both the vehicle control and the 
lowest dose of PEPs. Particularly, a dose-dependent elevation in the neutrophil percentage 
was visible across the three doses of instilled PEPs. Contrastingly, macrophage percentage 
in BALF was markedly lower in mice exposed to PEPs at 5 mg/kg when compared to both 
the vehicle control and the 0.5 mg/kg PEP exposure groups, suggesting enhanced adherence 
of macrophages to airway surfaces due to cell activation (Fig. 3C). The percent of 
lavageable lymphocytes also was noticeably lower at the highest PEP dose as opposed to the 
two lower PEP doses instilled (Fig. 3D).
3.3.3. Gene expression—Because our in vitro studies provided evidence of 
inflammatory response and oxidative damage due to exposure to PEPs, the expression of 
genes involved in these two important biological processes was evaluated in vivo. The lung 
tissue belonging to mice instilled with PEPs at 2.5 mg/kg was used to analyze the RNA and 
quantify the expression of a number of genes involved in inflammatory and oxidative 
damage responses. The genes evaluated included Egfr, Gpx1, Pparg, Stat3, Vegfa, Riiad1, 
Aox1, Sod1, Tgfb1, Nos1, Ccl5, Bcl2, Ucp2 and Akt1. In the PEP exposed group, there was 
an evident elevation in the fold induction of Nos1, Ccl5 and Ucp2 in comparison to the 
vehicle control group (Fig. 4).
3.3.4. Cytokine analysis—Out of 32 cytokines evaluated from the BALF of mice 
instilled with 2.5 mg/kg of PEPs, only leukemia inhibitory factor (LIF) was considerably 
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upregulated by exposure to PEPs when compared to the vehicle control exposure group (Fig. 
5).
3.3.5. Epigenetic alterations—Our previous in vitro studies clearly indicated that PEPs 
may affect the cellular epigenome within target cells. Here, exposure to 2.5 mg/kg of PEPs 
resulted in congruent epigenetic alterations. Fig. 6 shows the significant loss of DNA 
methyltransferase Dnmt3a and an elevated expression of TE LINE-1 observed in the whole 
lung tissue of mice instilled with PEPs.
4. Discussion
The aim of this study was to assess the effects of instilled PEPs emitted by laser printers 
using a mouse experimental model. This investigation is a part of a series of studies 
performed by our group to thoroughly evaluate the physicochemical, morphological and 
toxicological properties of PM emitted from laser printers (Pirela et al., 2014a,2014b, 2015; 
Sisler et al., 2014; Lu et al., 2015b) and developed an integrated methodology that can be 
used to link exposures from particulate matter released across life cycle of nano-enabled 
products to toxicology and adverse health effects. In particular, in this research study we 
focused on the effect of consumer relevant PM exposure on the inherent rodent biological 
response.
Here, we present data on the outcome of exposure of mice to PEPs by intratracheal 
instillation as it pertains to various endpoints of interest: lung injury and inflammation as 
well as epigenetic response.
The properties of the airborne PEPs were used to determine the range of doses of exposure 
used in the intratracheal instillation experiments. The material instilled in mice at 0.5, 2.5 
and 5.0 mg/kg is equivalent to approximately 14, 71 and 142 h of consumer inhalation 
exposure to PEPs. It is worth noting that during printing, in addition to the PEPs there are 
also gaseous emissions (i.e., VOCs) that may also have deleterious effects (may act 
synergistically with emitted PM) when inhaled. This study focuses solely on possible effects 
from particulate phase (PEPs) and further studies are required to assess potential effects 
from gaseous phase pollutants.
Intratracheal instillation exposure to relatively low doses of PEPs did not compromise lung 
membrane integrity evidenced by insignificant variations in levels of LDH or MPO in the 
lavage fluid of exposed mice. However, in regards to the increase of both percentage and 
number of neutrophils obtained in the bronchoalveolar lavage fluid following exposure to 
PEPs, there seems to be an increase that certainly appears to be dose-dependent based on the 
three doses of PEPs instilled. Specifically, there is a significant difference between the 
control and 0.5 mg/kg PEP (PM0.1) exposure groups to the 5.0 mg/kg bw PEP (PM0.1) 
group, and while there is no statistical difference between the 2.5 and 5.0 mg/kg PEP 
(PM0.1) exposure groups, there is a noticeable increase in the 5.0 mg/kg compared to the 2.5 
mg/kg. It is worth noting that the inflammatory response reported after a high dose 
instillation of PEPs agrees with the study by Pirela, Molina (Pirela et al., 2013), in which the 
number of neutrophils was upregulated following instillation of PM0.1 and PM0.1–2.5 
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sampled in commercial photocopier center. The percentage of macrophages harvested by 
BAL decreased at the high dose of PEPs, suggesting that alveolar macrophages were more 
adherent to airway surfaces due to PEP-induced cell activation. Another plausible 
explanation of why there was a reduced number of macrophages lavaged, may been due to a 
toxic effect of PEPs on the murine alveolar macrophages. A clear dose–response 
relationship was observed in a previous study assessing the toxicity of PEPs on THP-1 
macrophages (Pirela et al., 2015). Moreover, the reduction in lymphocytes at the highest 
PEP exposure compared to either the control group or the other two lower PEP doses, 
respectively, shows a regulation in the immune response to the exogenous PEPs. Lastly, in 
addition to no significant differences observed in the number of lymphocytes or 
macrophages between the PEPs exposed and the control groups, there are no discernable 
patterns in the macrophage and lymphocyte number population obtained in the 
bronchoalveolar lavage fluid. Therefore, no concluding statement can be made on this result.
After observing a substantial rise in expression of a variety of chemokines and cytokines in 
the in vitro toxicological assessments of PEPs (Sisler et al., 2014; Pirela et al., 2015), a 
similar inflammatory response could be expected following in vivo exposure to PEPs. 
However, out of 41 cytokines evaluated, only the expression of the LIF was significantly 
upregulated in mice instilled with PEPs (2.5 mg/kg) compared to the vehicle control. LIF is 
part of the IL-6 family of cytokines that is prominently elevated in pneumonia (Quinton et 
al., 2008). Principally, LIF has been associated with a protective role during pneumonia as 
well as having a central anti-inflammatory role during the early stages of an immune 
response (Quinton et al., 2012; Banner et al., 1998). Additionally, LIF was found to suppress 
cytokine production, cell death, airway hyperresponsiveness, alteration of epithelial 
membrane integrity and consequently, lung injury and inflammation Particularly, the 
suppression of LIF signaling can lead to enhanced gene expression of Ccl5 (RANTES) in 
small airway epithelial cells infected with the respiratory syncytial virus (Foronjy et al., 
2014). Perhaps, the distinct increase in LIF post-instillation to PEPs provides protection 
against PEP-induced lung injury. In our study, no suppression of LIF was observed by 
enhanced expression of Ccl5 and instead both LIF and Ccl5 were upregulated following 
exposure to PEPs. Possibly, levels of microRNAs (i.e., miR-302) that negatively regulate 
Ccl5 expression may be decreased due to PEP exposure, thus preventing the Ccl5 mRNA 
degradation and leading to increased cellular levels of the latter. However, this is a 
speculation and more analyses have to be performed to make definitive conclusions and 
further evaluate the signaling pathway occurring after acute exposure to PEPs.
Additionally, instillation of PEPs (2.5 mg/kg) caused a substantial rise in the gene 
expression levels of three genes, namely Ccl5 (RANTES), Nos1 and Ucp2. Of interest, Ccl5 
(RANTES) is a pro-inflammatory chemokine that plays an important role in the trafficking 
of natural killer, dendritic cells, macrophages and the activation of leukocytes (Aldinucci 
and Colombatti, 2014; Appay and Rowland-Jones, 2001). Ccl5 (RANTES) was one of the 
cytokines whose expression was also upregulated in both in vitro toxicology assessments of 
PEPs previously published by our group (Sisler et al., 2014; Pirela et al., 2015). More 
information is required to understand the association between gene expression changes and 
cytokine levels of LIF, involving further time course and dose response studies.
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The uncoupling protein 2 (Ucp2), one of three UCPs, is an inner mitochondrial membrane 
protein acting as a natural regulator of ROS in the mitochondria by reducing the formation 
of a large proton gradient independent of a thermogenic pathway. Thus, this family of 
proteins protects against oxidative stress (Patti and Corvera, 2010; Echtay et al., 2002; 
Andrews et al., 2008; Jastroch et al., 2010; Krauss et al., 2005). A study by Steer, Mann 
(Steer et al., 2013) showed a significant induction of Ucp2 in murine pulmonary alveolar 
macrophages following exposure to high concentrations of oxygen. Particularly, this 
increment in protein levels of Ucp2 occurs in response to a rise in mitochondrial ROS 
production. Substantial gene modulations of Ucp2 have been observed following exposures 
to other environmental stressors, such as arsenic, zinc oxide, octylphenol, nonylphenol, 
bisphenol A and tetrabromobisphenol A (Grasselli et al., 2014; Sarkar et al., 2014; Zhao et 
al., 2013; Song et al., 2012). Besides changes in expression of Ucp2, we observed a 
significant increase of Nos1 following exposure to PEPs. Nos1 is involved in the 
differentiation and function of immune cells in vitro and modulate immune responses and 
inflammatory process in vivo (Chakrabarti et al., 2012; Wahl et al., 2003; Martinelli et al., 
2009; Sellers et al., 2013). Nos1 is regulated by cytokines, microbial products, hormones 
and other intracellular factors (Forstermann et al., 1998; Iwase et al., 2000; Boissel et al., 
2004; Dudzinski et al., 2006). Moreover, it has been found that there is an interaction 
between the Nos1 gene and environmental factors, such as cigarette smoke, caffeine, and 
pesticides (Hancock et al., 2008). In a recent study (Levinsson et al., 2014), an association 
between polymorphisms in the Nos1 gene and coronary heart disease and hypertension was 
discovered; thus, identifying the gene as an important biomarker for these diseases. The 
increased expression of Nos1 and Ucp2 would suggest that exposure to PEPs may lead to 
oxidative stress in the lung. Further mechanistic studies are required to reveal possible 
interdependencies and multiple pathways associated with possible cardiopulmonary effects 
associated with PEPs.
Another important outcome of this study is the congruence of epigenetic alterations 
observed in our previous in vitro studies with the alterations observed in the current in vivo 
model. Specifically, we identified that expression of DNA methyltransferase (Dnmt3a), the 
enzyme involved in regulation of DNA methylation, was significantly diminished in the 
lung tissue after intratracheal instillation exposure to PEPs. This finding is in a good 
agreement with the down-regulation of Dnmt3a in human small airway epithelial cells, 
observed in our previous in vitro study 24 h after exposure to PEPs (Lu et al., 2015a). 
Furthermore, loss of Dnmt3a expression was also reported in several other studies, devoted 
to exposure to particles of various sizes — from coarse ambient particles to nanoparticles 
(Miousse et al., 2014a; Gong et al., 2010). These findings suggest that DNA 
methyltransferase (Dnmt3a) may be ubiquitously targeted by particles, and further studies 
are warranted to determine if it may be useful as an epigenetic biomarker of exposure in 
nanoparticle toxicology.
DNA methyltransferases are critical for proper establishment of DNA methylation, and 
within the TEs, in particular. Expression of LINE-1, the most abundant mammalian 
retrotransposon that comprises nearly 20% of their genome, is reported to be regulated by 
DNA methylation and directed by DNA methyltransferases (Bourc'his and Bestor, 2004; 
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Miousse and Koturbash, 2015). Loss of DNA methyltransferases expression may lead to the 
loss of global and TEs-associated DNA methylation (Jones, 2012; Miousse et al., 2014b; 
Koturbash et al., 2011). Interestingly, in this study, similar to our previous investigations in 
vitro,(Lu et al., 2015a) we identified a non-significant trend towards LINE-1 DNA 
hypermethylation 24 h after exposure to PEPs. Further studies with larger numbers of mice 
are needed to evaluate the effects of PEP exposure and determine the time course of this 
phenomenon.
Particle exposure may also result in reactivation of TEs (Miousse et al., 2014a; Koturbash et 
al., 2011). In this study, we observed increased expression of LINE-1 24 h post-exposure to 
PEPs, similar to our findings from the previously published in vitro study (Lu et al., 2015a). 
Reactivation of LINE-1 may result in increased rates of its retrotransposition that may 
subsequently lead to genomic instability and development of disease (Miousse and 
Koturbash, 2015). Further, the early DNA hypermethylation effect observed in this study 
may be related to the inhibition of Tet-1 enzyme involved in active conversion of 5-
methylcytosine into 5-hydroxymethylcytosine, which is a first step during the active DNA 
demethylation. This finding is in agreement with results published by our group recently (Lu 
et al., 2015a). LINE-1 mobilization, however, was not investigated in this study, since it has 
been shown that at least 120 h are needed in order to detect such event (Terasaki et al., 
2013).
Altogether, our epigenetic findings confirm the ability of PEPs to target the cellular 
epigenome and suggest that in vitro studies may be used, although with caution, to 
investigate the epigenetic mechanisms of response to PEPs. Furthermore, it has been 
suggested that epigenetic parameters can be utilized in risk assessment (Koturbash et al., 
2011; Goodman et al., 2010). Given congruent epigenetic responses observed in our in vitro 
and in vivo studies, further studies may support the use of epigenetic changes for the risk 
and safety assessment of nanomaterials. A large-scale study, investigating a platform of 
epigenetic alterations to a wide variety of nanomaterials both in vitro and in vivo, is clearly 
needed to identify specific parameters that can be further utilized for the assessment. Such 
study is currently underway in our laboratories and will be presented elsewhere in the future.
5. Conclusion
The study described here focuses on the assessment of toxicological potential of PEPs using 
an in vivo experimental animal model. Our data show that there may be an initiation of an 
immune response following the exposure to PEPs. Mice exposed to PEPs exhibited a variety 
of responses that translate into hallmarks of the initiation of an immune reaction due to the 
stress induced by PEPs. In toto, findings on lung injury, inflammation and changes in gene 
expression, point to possible adverse pulmonary effects. It is clear that these acute studies 
should be followed by more detailed sub-acute and chronic studies in order to have more 
conclusive evidence on deleterious effects from such a widely used nano-enabled product. 
Finally, this experimental approach used here linking exposures to particulate matter 
released across life cycle (called LCPM) could be used to study other NEPs for a more 
realistic risk assessment of nanomaterials and nano-enabled products.
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Fig. 1. 
Printer Exposure Generation System used to collect freshly generated PEPs for subsequent 
intratracheal instillations.
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Fig. 2. 
Deposition fraction of the mass of PEPs inhaled as a function of human lung generation 
number.
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Fig. 3. 
BAL cell responses following exposure to PEPs by intratracheal instillation. Percentage (A) 
and values (B) of lavaged neutrophils harvested by BAL. Percentage of lavaged 
macrophages (C) and lymphocytes (D). Values are expressed as means (±SD). Bar 
represents a significant difference between the two groups (p b 0.05).
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Fig. 4. 
Gene expression in lung tissue of mice instilled with PEPs (2.5 mg/kg). n = 3. * indicates 
significant difference when compared to the control exposure (p b 0.05).
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Fig. 5. 
Expression levels of the leukemia inhibitory factor (LIF) chemokine in the bronchoalveolar 
lavage fluid of mice exposed to PEPs (2.5 mg/kg). * indicates significant difference when 
compared to the control exposure (p b 0.05).
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Fig. 6. 
Fold changes in methylation/expression of Dnmt3a and LINE-1 in murine lung tissue 
following exposure to PEPs (2.5 mg/kg). * indicates significant difference when compared 
to the control exposure (p b 0.05).
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Table 1
Summary of parameters used in the human lung Multiple Path Particle Deposition model (MPPD2).
Human model Breathing parameters Airborne nanoparticle distribution
Functional residual capacity: 3300 mL Tidal volume: 625 mL Count mean diameter: 57.45 nm
Head volume: 50 mL Breathing frequency: 12 breaths/min Geometric standard deviation: 1.67
Breathing route: nasal Inspiratory fraction: 0.5 Mass concentration: 23.86 μg/m3
Pause fraction: 0.0
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Table 2
Comparison of doses of murine PEP exposures used in the study by intratracheal instillation with comparable 
human inhalation exposures to PEPs.
PEP exposure by intratracheal instillation (mg/kg bw) Duration of consumer inhalation exposure of PEPs (h)
0.5 13.7
2.5 70.9
5.0 141.9
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Table 3
Properties of laser printer emitted particle dispersions in DI H2O. dH: hydrodynamic diameter, PdI: 
polydispersity index, ζ: zeta potential, σ: specific conductance.
Material Media dH (nm) PdI ζ (mV) σ (mS/cm)
PEPs (PM0.1) DI H2O 178.3 ± 3.459 0.403 ± 0.050 –20.6 ± 1.87 0.185 ± 5.8 × 10–4
Notes: values represent the mean (±SD) of a triplicate reading.
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